Trial intelligence / Profile preview

Polyethylene glycol single-dose vs divided-dose in pediatric functional constipation

IRCT20090908002434N9Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Oct 2021
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 3, randomised trial of macrogol in functional constipation (FC) (2 arms), sponsored by Shiraz University of Medical Sciences. Started Oct 2021; status: completed.

02

Drugs

macrogol
03

Conditions

functional constipation (FC)

Beyond the preview

Go deeper on IRCT20090908002434N9.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20090908002434N9.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call